Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels

Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels

This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA network open 2022-11, Vol.5 (11), p.e2240513-e2240513
Hauptverfasser: O'Neil, Adam, Calderbank, Steve, Brown, James, Vandigo, Joe, Yin, Perry, Bratti, Keith, Howell, Scott
Format: Artikel
Sprache:eng
Schlagworte:
Health Policy
Humans
Lipids
Online Only
PCSK9 Inhibitors
Research Letter
Retrospective Studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
ISSN:2574-3805
2574-3805
DOI:10.1001/jamanetworkopen.2022.40513